Suvorexant
Drug timelines are a Plus or Pro feature.
36 regulatory and trial events tracked for Suvorexant, covering 2014-08-29 to 2026-08-12. Get the full timeline:
Most recent: Clinical Trial Results: Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors [Phase 4]